Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Riffyn Awarded Its First US Patent for Experiment Design and Data Analytics

Riffyn
Posted on: 27 Feb 18
Riffyn Awarded Its First US Patent for Experiment Design and Data Analytics

Newly patented hypergraph data model solidifies Riffyn’s position in the expanding market for linked-data analytics and AI in biotech and pharmaceutical R&D

Oakland, CA, USA, 27th February 2018 / Sciad NewswireRiffyn, a provider of cloud-based R&D software, announced that the United States Patent Office has granted its patent on a hypergraph data model for experiment design and data analysis (U.S. Patent No. 9,910,936). This technology is the foundation of Riffyn’s Scientific Development Environment (SDE) — paradigm-changing software used to speed scientific discovery and development.

“Global pharma, biotech and chemical enterprises are under tremendous pressure to shorten product development cycles to address product obsolescence, pricing pressures, and realize first-to-market advantages,” noted Dr. Timothy Gardner, Riffyn’s Founder/CEO. “The Riffyn SDE offers these companies a fundamentally unique path to digital transformation, harnessing linked-data analytics to shorten product development cycles.”

Enterprises seeking digital transformation of their R&D processes are currently impeded by unparalleled data complexity and heterogeneity. Consequently, integration of that data for analysis requires laborious and time-consuming manual effort. The Riffyn SDE solves the integration problem by automatically annotating and reshaping diverse scientific datasets for machine learning. Thus, Riffyn SDE users can shift their efforts away from low-value data management to high-value discovery activities that harness AI, quality-by-design, and visual analytics.

Over $200 billion is spent each year on life science R&D, with $142 billion spent in biopharmaceutical industry R&D alone. Of that spend, approximately 8% ($11.4B) is spent on information technology. Riffyn will utilize the patent to advance its position in this rapidly expanding market. In particular, it will strengthen Riffyn’s capabilities for streaming fully-annotated and uniformly-structured data to R&D data lakes, one of the fastest growing areas of IT investment. Riffyn predicts continued rapid growth in 2018, following its outstanding 2017 performance that delivered a 1000% increase in year-on-year revenue.

Ends

For further information contact:

Riffyn
Tom Bourgoin
E: media@riffyn.com
T: +1-510-543-0077

Sciad Communications, Media Relations
Emma Pickup / Deborah Cockerill / Juliette Craggs
E: riffyn@sciad.com
T: +44 (0)20 7470 8801

Notes to Editors

About Riffyn
Riffyn is a provider of research design and analytics software (SaaS) to biotech, pharmaceutical, food and chemical industries. Riffyn’s cloud-based Scientific Development Environment (Riffyn SDE) delivers trustworthy data and real-time analytics to R&D organizations who want more productive, reliable science. The Riffyn SDE gives customers the power to achieve repeatable outcomes, faster discoveries, and right-first-time technology scale-up. Riffyn serves enterprise R&D customers across the US, Asia, Europe and South America, and has offices in Oakland, CA and Boston, MA. For more information, visit: www.riffyn.com. Riffyn has previously raised $12 million in venture financing.

References
Transforming Productivity, 2017, Riffyn
https://riffyn.com/impact#transforming-productivity-1b

2017 R&D Magazine Global Funding Forecast, 2016, R&D Magazine
http://digital.rdmag.com/researchanddevelopment/2017_global_r_d_funding_forecast?pg=1#pg1

Research Life Sciences Cloud (RLSC), 2015, Merck
http://www.prismeforum.org/wp-content/uploads/2015/06/RLSC-2015-PRISME.pdf

For more information:
www.sciadnewswire.com/news/440/riffyn-awarded-its-first-us-patent-experiment-design-and-data-analytics

Editor's Details

Juliette Craggs
Sciad Communications
+44 (0)20 7470 8801
riffyn@sciad.com

Last updated on: 27/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.